High conservation of varicella-zoster virus helicase-primase complex, the target of the new antiviral drug amenamevir-Reference-Cited by-同舟云学术

High conservation of varicella-zoster virus helicase-primase complex, the target of the new antiviral drug amenamevir

Published:2021-11 Issue: Volume:195 Page:105189
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Pacreau Marie-Liesse,Bomme Olivier,Burrel Sonia^ORCID,Boutolleau David^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference25 articles.

1. Advances and perspectives in the management of varicella-zoster virus infections;Andrei;Molecules,2021

2. Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1;Biswas;J. Antimicrob. Chemother.,2007

3. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure;Biswas;J. Gen. Virol.,2009

4. Emergence of Varicella Zoster Virus Resistance to Acyclovir Among Both Immunocompromised and Immunocompetent Individuals. Oral Communication 00820;Boutolleau,2019

5. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals;Burrel;Antimicrob. Agents Chemother.,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?;International Journal of Molecular Sciences;2022-03-22